0001516513FALSE00015165132024-02-082024-02-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________________________________________________________________
FORM 8-K
_________________________________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 8, 2024
_________________________________________________________________________________________________________________
Doximity, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________________________________________________________________________________________________
Delaware001-4050827-2485512
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)
500 3rd St.
Suite 510
San Francisco, CA 94107
(Address of principal executive offices, including zip code)
(650) 549-4330
(Registrant's telephone number, including area code)
_______________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.001 par value per shareDOCSThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02 – Results of Operations and Financial Condition
On February 8, 2024, Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter ended December 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.
The information provided in this Item 2.02 of this Current Report on Form 8-K, and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
Exhibit NumberDescription
99.1
104Cover Page Interactive Data File (embedded within the inline XBRL document)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 8, 2024
DOXIMITY, INC.
By:
/s/ Anna Bryson
Anna Bryson
Chief Financial Officer



Exhibit 99.1
Doximity Announces Fiscal 2024 Third Quarter Financial Results
Total revenues of $135.3 million, up 17% year-over-year
Net income margin of 35% and adjusted EBITDA margin of 54%
Net income growth of 43% and adjusted EBITDA growth of 32% year-over-year

SAN FRANCISCO, Calif., February 8, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 third quarter ended December 31, 2023.
"We’re proud to deliver another quarter of double-digit engagement growth across our entire platform, with a beat and raise on both our top and bottom lines,” said Jeff Tangney, co-founder and CEO of Doximity. “Our clinical workflow tools continue to drive daily use among doctors, and we now count 17 of the top 22 U.S. hospitals as enterprise software clients.”
Fiscal 2024 Third Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months ended December 31, 2022.
•Revenue: Revenue of $135.3 million, versus $115.3 million, an increase of 17% year-over-year.
•Net income and non-GAAP net income: Net income of $48.0 million, versus $33.5 million, representing a margin of 35.4%, versus 29.0%. Non-GAAP net income of $58.5 million, versus $45.8 million, representing a margin of 43.2%, versus 39.7%.
•Adjusted EBITDA: Adjusted EBITDA of $73.3 million, versus $55.5 million, an increase of 32% year-over-year, representing adjusted EBITDA margins of 54.2%, versus 48.2%.
•Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.24, versus $0.16, while non-GAAP diluted net income per share was $0.29, versus $0.22.
•Operating cash flow and free cash flow: Operating cash flow of $50.1 million, versus $48.7 million, an increase of 3% year-over-year, and free cash flow of $48.7 million, versus $47.5 million, an increase of 3% year-over-year.
Financial Outlook
Doximity is providing guidance for its fiscal fourth quarter ending March 31, 2024 as follows:
•Revenue between $115.9 million and $116.9 million.
•Adjusted EBITDA between $50.5 million and $51.5 million.
Doximity is updating guidance for its fiscal year ending March 31, 2024 as follows:
•Revenue between $473.3 million and $474.3 million.
•Adjusted EBITDA between $224.5 million and $225.5 million.
1

Conference Call Information
Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit www.doximity.com.
Forward-Looking Statements
Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Investor Relations Contact:
Perry Gold
ir@doximity.com
Media Contact:
Amanda Cox
pr@doximity.com




2

DOXIMITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
December 31, 2023March 31, 2023
Assets
Current assets:
Cash and cash equivalents$123,089 $158,027 
Marketable securities587,149 682,972 
Accounts receivable, net 97,584 107,047 
Prepaid expenses and other current assets27,191 22,289 
Deferred contract costs, current5,886 5,118 
Total current assets840,899 975,453 
Property and equipment, net11,839 11,279 
Deferred income tax assets37,204 34,907 
Operating lease right-of-use assets12,808 13,819 
Intangible assets, net28,379 31,836 
Goodwill67,940 67,940 
Other assets1,580 1,654 
Total assets$1,000,649 $1,136,888 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$1,880 $1,272 
Accrued expenses and other current liabilities34,079 31,245 
Deferred revenue, current66,694 105,238 
Operating lease liabilities, current2,109 1,752 
Total current liabilities104,762 139,507 
Deferred revenue, non-current166 198 
Operating lease liabilities, non-current12,947 13,885 
Contingent earn-out consideration liability, non-current10,787 15,942 
Income taxes payable, non-current
6,532 99 
Other liabilities, non-current841 1,141 
Total liabilities136,035 170,772 
Stockholders' Equity
Preferred stock— — 
Common stock186 194 
Additional paid-in capital808,078 762,150 
Accumulated other comprehensive loss(4,653)(14,083)
Retained earnings61,003 217,855 
Total stockholders' equity864,614 966,116 
Total liabilities and stockholders’ equity$1,000,649 $1,136,888 

3

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
Revenue$135,284 $115,262 $357,365 $308,086 
Cost of revenue(1)
12,190 13,526 38,102 39,813 
Gross profit123,094 101,736 319,263 268,273 
Operating expenses(1):
Research and development19,946 20,519 61,835 58,645 
Sales and marketing34,956 33,220 99,612 90,375 
General and administrative9,641 9,513 27,854 26,986 
Restructuring— — 7,936 — 
Total operating expenses64,543 63,252 197,237 176,006 
Income from operations58,551 38,484 122,026 92,267 
Other income, net4,481 2,461 15,223 4,173 
Income before income taxes63,032 40,945 137,249 96,440 
Provision for income taxes15,076 7,477 30,285 14,290 
Net income$47,956 $33,468 $106,964 $82,150 
Net income per share attributable to Class A and Class B common stockholders:
Basic$0.26 $0.17 $0.56 $0.43 
Diluted$0.24 $0.16 $0.52 $0.38 
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic186,309 192,805 191,302 192,963 
Diluted200,463 212,065 207,265 213,656 
(1) Costs and expenses include stock-based compensation expense as follows (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
Cost of revenue$2,466 $2,695 $7,205 $7,209 
Research and development3,080 4,002 8,874 9,416 
Sales and marketing4,060 4,856 12,752 11,912 
General and administrative2,165 2,431 6,742 6,306 
Restructuring— — 3,646 — 
Total stock-based compensation expense$11,771 $13,984 $39,219 $34,843 
4

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
Cash flows from operating activities
Net income$47,956 $33,468 $106,964 $82,150 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization2,509 2,616 7,717 7,575 
Deferred income taxes— 9,287 — 9,392 
Stock-based compensation, net of amounts capitalized11,771 13,984 39,219 34,843 
Non-cash lease expense522 538 1,599 1,490 
Amortization of premium (accretion of discount) on marketable securities, net(1,683)471 (3,477)3,144 
Loss on sale of marketable securities260 593 402 1,093 
Amortization of deferred contract costs1,548 1,518 6,278 6,357 
Change in fair value of contingent earn-out consideration liability
452 417 768 323 
Other788 373 457 474 
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable(1,135)3,997 8,509 6,191 
Prepaid expenses and other assets6,523 (1,727)(3,981)1,924 
Deferred contract costs(4,477)(4,067)(6,925)(6,409)
Accounts payable, accrued expenses and other liabilities10,429 7,197 2,366 2,723 
Deferred revenue(24,823)(19,970)(38,576)(18,098)
Operating lease liabilities(586)2 (1,168)(209)
Net cash provided by operating activities50,054 48,697 120,152 132,963 
Cash flows from investing activities
Cash paid for acquisition— — — (53,500)
Purchases of property and equipment(36)(204)(147)(1,680)
Internal-use software development costs(1,288)(1,012)(4,020)(3,478)
Purchases of marketable securities(101,112)(39,080)(281,338)(130,257)
Maturities of marketable securities105,418 10,576 318,186 35,014 
Sales of marketable securities37,150 43,024 74,675 107,182 
Net cash provided by (used in) investing activities40,132 13,304 107,356 (46,719)
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants2,540 1,871 9,758 7,455 
Proceeds from issuance of common stock in connection with the employee stock purchase plan— — 1,494 2,341 
Taxes paid related to net share settlement of equity awards(1,248)(1,092)(5,332)(2,353)
Repurchase of common stock(76,792)— (262,976)(70,042)
Payment of contingent consideration related to a business combination— — (5,390)— 
Net cash provided by (used in) financing activities(75,500)779 (262,446)(62,599)
Net increase (decrease) in cash and cash equivalents14,686 62,780 (34,938)23,645 
Cash and cash equivalents, beginning of period108,403 73,674 158,027 112,809 
Cash and cash equivalents, end of period
$123,089 $136,454 $123,089 $136,454 
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds
$8,925 $2,381 $38,363 $2,504 

5

Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:
•Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, restructuring expense, change in fair value of contingent earn-out consideration liability, and acquisition and other related expenses from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
•Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, restructuring expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
•Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.
We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.
Key Business Metrics
•Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
•Customers with trailing 12-month subscription revenue greater than $100,000 and $1 million: The number of customers with TTM subscription revenue greater than $100,000 and $1 million is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $100,000 and $1 million in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.
6

Reconciliation of GAAP to Non-GAAP Financial Measures
The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
(unaudited)
(in thousands, except percentages)
Net income$47,956 $33,468 $106,964 $82,150 
Adjusted to exclude the following:
Acquisition and other related expenses— — — 30 
Stock-based compensation11,771 13,984 35,573 34,843 
Depreciation and amortization2,509 2,616 7,717 7,575 
Provision for income taxes15,076 7,477 30,285 14,290 
Restructuring expense
— — 7,936 — 
Change in fair value of contingent earn-out consideration liability452 417 768 323 
Other income, net(4,481)(2,461)(15,223)(4,173)
Adjusted EBITDA$73,283 $55,501 $174,020 $135,038 
Revenue$135,284 $115,262 $357,365 $308,086 
Net income margin35.4 %29.0 %29.9 %26.7 %
Adjusted EBITDA margin54.2 %48.2 %48.7 %43.8 %

Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
(unaudited)
(in thousands)
Net cash provided by operating activities$50,054 $48,697 $120,152 $132,963 
Purchases of property and equipment(36)(204)(147)(1,680)
Internal-use software development costs(1,288)(1,012)(4,020)(3,478)
Free cash flow$48,730 $47,481 $115,985 $127,805 
Other cash flow components:
Net cash provided by (used in) investing activities$40,132 $13,304 $107,356 $(46,719)
Net cash provided by (used in) financing activities$(75,500)$779 $(262,446)$(62,599)
7

Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
(unaudited)
(in thousands, except per share data and percentages)
GAAP cost of revenue$12,190 $13,526 $38,102 $39,813 
Adjusted to exclude the following:
Stock-based compensation(2,466)(2,695)(7,205)(7,209)
Amortization of acquired intangibles— (137)(274)(410)
Non-GAAP cost of revenue$9,724 $10,694 $30,623 $32,194 
GAAP gross profit$123,094 $101,736 $319,263 $268,273 
Adjusted to exclude the following:
Stock-based compensation2,466 2,695 7,205 7,209 
Amortization of acquired intangibles— 137 274 410 
Non-GAAP gross profit$125,560 $104,568 $326,742 $275,892 
GAAP gross margin91.0 %88.3 %89.3 %87.1 %
Non-GAAP gross margin92.8 %90.7 %91.4 %89.6 %
GAAP research and development expense$19,946 $20,519 $61,835 $58,645 
Adjusted to exclude the following:
Stock-based compensation(3,080)(4,002)(8,874)(9,416)
Non-GAAP research and development expense$16,866 $16,517 $52,961 $49,229 
GAAP sales and marketing expense$34,956 $33,220 $99,612 $90,375 
Adjusted to exclude the following:
Stock-based compensation(4,060)(4,856)(12,752)(11,912)
Amortization of acquired intangibles(1,061)(1,061)(3,183)(3,185)
Change in fair value of contingent earn-out consideration liability(452)(417)(768)(323)
Non-GAAP sales and marketing expense$29,383 $26,886 $82,909 $74,955 
GAAP general and administrative expense$9,641 $9,513 $27,854 $26,986 
Adjusted to exclude the following:
Acquisition and other related expenses— — — (30)
Stock-based compensation(2,165)(2,431)(6,742)(6,306)
Non-GAAP general and administrative expense$7,476 $7,082 $21,112 $20,650 
GAAP operating expense$64,543 $63,252 $197,237 $176,006 
Adjusted to exclude the following:
Acquisition and other related expenses— — — (30)
Stock-based compensation(9,305)(11,289)(28,368)(27,634)
Amortization of acquired intangibles(1,061)(1,061)(3,183)(3,185)
Change in fair value of contingent earn-out consideration liability(452)(417)(768)(323)
Restructuring— — (7,936)— 
Non-GAAP operating expense$53,725 $50,485 $156,982 $144,834 
8

Three Months Ended December 31,Nine Months Ended December 31,
2023202220232022
(unaudited)
(in thousands, except per share data and percentages)
GAAP operating income$58,551 $38,484 $122,026 $92,267 
Adjusted to exclude the following:
Acquisition and other related expenses— — — 30 
Stock-based compensation11,771 13,984 35,573 34,843 
Amortization of acquired intangibles1,061 1,198 3,457 3,595 
Change in fair value of contingent earn-out consideration liability452 417 768 323 
Restructuring— — 7,936 — 
Non-GAAP operating income$71,835 $54,083 $169,760 $131,058 
GAAP net income$47,956 $33,468 $106,964 $82,150 
Adjusted to exclude the following:
Acquisition and other related expenses— — — 30 
Stock-based compensation11,771 13,984 35,573 34,843 
Amortization of acquired intangibles1,061 1,198 3,457 3,595 
Change in fair value of contingent earn-out consideration liability452 417 768 323 
Restructuring— — 7,936 — 
Income tax effect of non-GAAP adjustments (1)
(2,790)(3,276)(10,024)(8,146)
Non-GAAP net income$58,450 $45,791 $144,674 $112,795 
Non-GAAP net income margin43.2 %39.7 %40.5 %36.6 %
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic186,309 192,805 191,302 192,963 
Diluted200,463 212,065 207,265 213,656 
Non-GAAP net income per share attributable to Class A and Class B stockholders:
Basic$0.31 $0.24 $0.76 $0.58 
Diluted$0.29 $0.22 $0.70 $0.53 
(1) For the three and nine months ended December 31, 2023 and 2022, management used an estimated annual effective non-GAAP tax rate of 21.0%.
9
v3.24.0.1
Cover
Feb. 08, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 08, 2024
Entity Registrant Name Doximity, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40508
Entity Tax Identification Number 27-2485512
Entity Address, Address Line One 500 3rd St.
Entity Address, Address Line Two Suite 510
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94107
City Area Code 650
Local Phone Number 549-4330
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A common stock, $0.001 par value per share
Trading Symbol DOCS
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001516513
Amendment Flag false
Doximity (NYSE:DOCS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Doximity 차트를 더 보려면 여기를 클릭.
Doximity (NYSE:DOCS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Doximity 차트를 더 보려면 여기를 클릭.